Advertisement

  • Worth the Wait

    Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.

    by Sharon Tregaskis

  • Our Own Words

    People with cancer and their loved ones find ways for their voices to be heard without filters.

    by Bradley Jones

  • Survivor Profile

    Still in the Game

    ESPN reporter Holly Rowe worked through melanoma treatment.

    by Lindsey Konkel

  • Q&A

    Dissecting Mental Illness

    Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain.

    by Marci A. Landsmann

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • Forward Look

    Tackling Drug Resistance

    Researchers are studing new ways to keep treatments working longer.

    by Stephen Ornes

  • Survivor Profile

    Living in the Here and Now

    A metastatic melanoma survivor is hopeful but realistic as new treatments become available.

    by Jenny Song

  • Forward Look

    Cancer Immunotherapies Continue to Make Headway

    Drugs that harness the power of the immune system gain new approvals.

    by Alexandra Goho

  • Survivor Profile

    Knowing Her Options

    When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors.

    by Melissa Davlin

  • First Person

    Keeping Sight of Hope

    A survivor keeps an eye on what's ahead after a rare cancer diagnosis.

    by Sue Russell

Advertisement
Advertisement

From the AACR

  • Cervical Cancer Awareness

    The incidence of cervical cancer has been decreasing in the U.S. in recent decades, aided by the implementation of human papillomavirus vaccines.

  • Breast Cancer and COVID-19

    Patients with cancer have a higher risk of mortality from COVID-19, and the pandemic is disproportionately affecting racial and ethnic minorities.

  • Harnessing Genomic Data

    As AACR Project GENIE marked its fifth anniversary, more than 7,900 individuals are registered to use the public data, and 296 papers have cited the registry.

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR